Table 1. Patients, tumors and blood cell count characteristics.
| Characteristics | Median (min-max) or Nb(%) | |
|---|---|---|
| Number of patients | 113 (100) | |
| Age (years) | 48.3 (24.7–74.4) | |
| Performance status | 0 | 85 (75.2) |
| 1 | 26 (23.0) | |
| 2 | 2 (1.8) | |
| Histopathological type: | SCC | 95 (84.1) |
| ADK | 18 (15.9) | |
| Tumor volume (cm3) | 39.7 (10.5–340) | |
| Largest tumor size (cm) | 4.7 (1–12) | |
| Maximal size > 5 cm | Yes | 61 (46.0) |
| No | 52 (54.0) | |
| FIGO staging | IB2 | 33 (29.2) |
| IIA | 7 (6.2) | |
| IIB | 51 (45.1) | |
| IIIA | 1 (0.9) | |
| IIIB | 3 (2.7) | |
| IVA | 5 (4.4) | |
| IVB | 13 (11.5) | |
| Pelvic nodal metastases | Yes | 45 (39.8) |
| No | 68 (60.2) | |
| Differentiation degree | Well | 27 (23.9) |
| Moderate | 42 (37.2) | |
| Poor | 17 (15) | |
| ND | 27 (23.9) | |
| Blood cell count at first week | ||
| Hemoglobin (g/dl) | 12.6 (6.5–15.3) | |
| Platelet (G/L) | 286 (110–751) | |
| Leucocytes (/mm3) | 8,800 (3,700–22,500) | |
| Neutrophils (/mm3) | 5,650 (400–18,700) | |
| Leucocytosis | Yes | 28 (24.8) |
| No | 85 (75.2) | |
| Neutrophilia | Yes | 28 (24.8) |
| No | 85 (75.2) |
ADK: adenocarcinoma; FIGO: International Federation of Gynecology Obstetrics; SCC: squamous cell carcinoma; Nb: number.